未登录 Intermediate endpoints as surrogates for long-term outcomes in breast cancer adjuvant chemotherapy trials 中间终点作为长期结局的替代指标在乳腺癌辅助化疗试验中的应用 Blasco, Andrea; Lopez-Tarruella, Sara; Urruticoechea, Ander; Carrasco, Eva; Spera, Gonzalo; Martin, Miguel; Bermejo, Begona; Chap, Linnea; Ruiz-Borrego, Manuel; Crown, John; Garcia-Saenz, Jose A.; Chan, Arlene; Guerrero-Zotano, Angel; Semiglazov, Vladimir; Calvo, Lourdes; Pienkowski, Tadeusz; Herranz, Jesus; Slamon, Dennis 分享 收藏
分享 收藏
Body mass index as a predictive factor for efficacy of adjuvant taxane-based chemotherapy in early-stage breast cancer patients: A pooled analysis from adjuvant GEICAM Spanish Breast Cancer Group and TRIO Translational Research in Oncology Group studies Garcia-Saenz, Jose A.; Spera, Gonzalo; Pollan, Marina; Bermejo, Begona; Ruiz-Borrego, Manuel; Chan, Arlene; Martin, Miguel; Guerrero-Zotano, Angel; Calvo, Lourdes; Rodriguez-Lescure, Alvaro; Marin, Maria; Chap, Linnea; Crown, John; Pienkowski, Tadeusz; Bee, Valerie; Casas, Maribel; Polonio, Oscar; Bezares, Susana; Slamon, Dennis 分享 收藏
分享 收藏
The cancer-risk variant frequency among Polish population reported by the first national whole-genome sequencing study Mroczek, Magdalena; Liu, Jakub; Sypniewski, Mateusz; Pienkowski, Tadeusz; Itrych, Bartosz; Stojak, Joanna; Pronobis-Szczylik, Bartosz; Stepien, Maria; Kaja, Elzbieta; Dabrowski, Maciej; Suchocki, Tomasz; Wojtaszewska, Marzena; Zawadzki, Pawel; Mach, Anna; Sztromwasser, Pawel; Krol, Zbigniew J.; Szyda, Joanna; Dobosz, Paula 分享 收藏
GLORIA: phase III, open-label study of adagloxad simolenin/OBI-821 in patients with high-risk triple-negative breast cancer Rugo, Hope S.; Cortes, Javier; Barrios, Carlos H.; Cabrera, Paula; Xu, Binghe; Huang, Chiun-Sheng; Kim, Sung-Bae; Melisko, Michelle; Nanda, Rita; Pienkowski, Tadeusz; Rapoport, Bernardo L.; Schwab, Richard 分享 收藏
Genetic Polymorphisms and Correlation with Treatment-Induced Cardiotoxicity and Prognosis in Patients with Breast Cancer 乳腺癌患者的基因多态性及其与治疗引起的心脏毒性和预后的相关性 Peddi, Parvin F.; Fasching, Peter A.; Liu, Duan; Quinaux, Emmanuel; Robert, Nicholas J.; Valero, Vicente; Crown, John; Falkson, Carla; Brufsky, Adam; Cunningham, Julie M.; Weinshilboum, Richard M.; Pienkowski, Tadeusz; Eiermann, Wolfgang; Martin, Miguel; Bee, Valerie; Wang, Xiaoyan; Wang, Liewei; Yang, Eric; Slamon, Dennis J.; Hurvitz, Sara A. 分享 收藏
The TRAR gene classifier to predict response to neoadjuvant therapy in HER2-positive and ER-positive breast cancer patients: an explorative analysis from the NeoSphere trial TRAR基因分类器预测HER2-positive和ER阳性乳腺癌患者对新辅助治疗的反应: 来自NeoSphere试验的探索性分析 Triulzi, Tiziana; Bianchini, Giampaolo; Di Cosimo, Serena; Pienkowski, Tadeusz; Im, Young-Hyuck; Bianchi, Giulia Valeria; Galbardi, Barbara; Dugo, Matteo; De Cecco, Loris; Tseng, Ling-Ming; Liu, Mei-Ching; Bermejo, Begona; Semiglazov, Vladimir; Viale, Giulia; de la Haba-Rodriguez, Juan; Oh, Do-Youn; Poirier, Brigitte; Valagussa, Pinuccia; Gianni, Luca; Tagliabue, Elda 分享 收藏
Impact of body mass (BMI) and weight change after adjuvant treatment in patients (pts) with HER2-positive early breast cancer Franzoi, M. A.; Martel, S.; Agbor-Tarh, D.; Piccart, M.; Bines, J.; Loibl, S.; Di Cosimo, S.; Vaz-Luis, I.; Di Meglio, A.; Del Mastro, L.; Gombos, A.; Desmedt, C.; Jerusalem, G.; Reaby, L.; Pienkowski, T.; Lambertini, M.; de Azambuja, E. 分享 收藏
分享 收藏
Association of immune gene expression with outcome in the MARIANNE phase 3 clinical trial in HER2-positive metastatic breast cancer (MBC) Perez, Edith A.; de Haas, Sanne Lysbet; Barrios, Carlos H.; Eiermann, Wolfgang; Toi, Masakazu; Im, Young-Hyuck; Conte, Pier Franco; Martin, Miguel; Pienkowski, Tadeusz; Pivot, Xavier B.; Burris, Howard A., III; Lambertini, Chiara; Hoersch, Silke; Patre, Monika; Ellis, Paul Anthony 分享 收藏
Interim overall survival analysis of APHINITY (BIG 4-11): A randomized multicenter, double-blind, placebo-controlled trial comparing chemotherapy plus trastuzumab plus pertuzumab versus chemotherapy plus trastuzumab plus placebo as adjuvant therapy in patients with operable HER2-positive early breast cancer Piccart, Martine; Procter, Marion; Fumagalli, Debora; de Azambuja, Evandro; Clark, Emma; Ewer, Michael S.; Restuccia, Eleonora; Jerusalem, Guy; Dent, Susan; Reaby, Linda; Bonnefoi, Herve; Krop, Ian; Liu, Tsang-Wu; Pienkowski, Tadeusz; Toi, Masakazu; Wilcken, Nicolas; Andersson, Michael; Im, Young-Hyuck; Tseng, Ling-Ming; Lueck, Hans-Joachim; Colleoni, Marco; Monturus, Estefania; Sicoe, Mihaela; Guillaume, Sebastien; Bines, Jose; Gelber, Richard; Viale, Giuseppe; Thomssen, Christoph 分享 收藏
Trastuzumab emtansine with or without pertuzumab versus trastuzumab with taxane for human epidermal growth factor receptor 2-positive advanced breast cancer: Final results from MARIANNE 曲妥珠单抗emtansine联合或不联合帕妥珠单抗与曲妥珠单抗联合紫杉烷治疗人类表皮生长因子受体2阳性晚期乳腺癌: 来自MARIANNE的最终结果 Perez, Edith A.; Barrios, Carlos; Eiermann, Wolfgang; Toi, Masakazu; Im, Young-Hyuck; Conte, Pierfranco; Martin, Miguel; Pienkowski, Tadeusz; Pivot, Xavier B.; Burris, Howard A., III; Petersen, Jennifer A.; De Haas, Sanne; Hoersch, Silke; Patre, Monika; Ellis, Paul Anthony 分享 收藏
Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer (vol 19, 517, 2019) Perez, Edith A.; de Haas, Sanne Lysbet; Eiermann, Wolfgang; Barrios, Carlos H.; Toi, Masakazu; Im, Young-Hyuck; Conte, Pier Franco; Martin, Miguel; Pienkowski, Tadeusz; Pivot, Xavier B.; Burris, Howard A.; Stanzel, Sven; Patre, Monika; Ellis, Paul Anthony 分享 收藏
Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer Perez, Edith A.; de Haas, Sanne Lysbet; Eiermann, Wolfgang; Barrios, Carlos H.; Toi, Masakazu; Im, Young-Hyuck; Conte, Pier Franco; Martin, Miguel; Pienkowski, Tadeusz; Pivot, Xavier B.; Burris, Howard A., III; Stanzel, Sven; Patre, Monika; Ellis, Paul Anthony 分享 收藏
HER2/ERBB2 status in HER2 equivocal breast cancers by FISH and ASCO-CAP guidelines: False-positives due to heterozygous deletions of alternative control loci Press, M. F.; Seoane, J. A.; Curtis, C.; Quinaux, E.; Guzman, R.; Sauter, G.; Eiermann, W.; Mackey, J. R.; Robert, N.; Pienkowski, T.; Crown, J.; Martin, M.; Valero, V.; Bee, V.; Ma, Y.; Villalobos, I.; Slamon, D. J. 分享 收藏
Proliferation and p21 refine risk of relapse in residual disease after HER2-directed therapies Bianchini, G.; Pienkowski, T.; Im, Y-H; Bianchi, G. V.; Tseng, L-M; Liu, M-C; Lluch, A.; de la Haba-Rodrguez, J.; Semiglazov, V.; Oh, D-Y; Poirier, B.; Pedrini, J. L.; Valagussa, P.; Gianni, L. 分享 收藏
Biomarker analysis of the NeoSphere study: pertuzumab, trastuzumab, and docetaxel versus trastuzumab plus docetaxel, pertuzumab plus trastuzumab, or pertuzumab plus docetaxel for the neoadjuvant treatment of HER2-positive breast cancer NeoSphere研究的生物标志物分析: 帕妥珠单抗、曲妥珠单抗和多西他赛与曲妥珠单抗联合多西他赛、帕妥珠单抗联合曲妥珠单抗或帕妥珠单抗联合多西他赛用于HER2-positive乳腺癌新辅助治疗的比较 Bianchini, Giampaolo; Kiermaier, Astrid; Bianchi, Giulia Valeria; Im, Young-Hyuck; Pienkowski, Tadeusz; Liu, Mei-Ching; Tseng, Ling-Ming; Dowsett, Mitch; Zabaglo, Lila; Kirk, Sarah; Szado, Tania; Eng-Wong, Jennifer; Amler, Lukas C.; Valagussa, Pinuccia; Gianni, Luca 分享 收藏
Baseline molecular markers and risk of distant relapse in the NeoSphere study Bianchini, Giampaolo; Pienkowski, Tadeusz; Im, Young-Hyuck; Bianchi, Giulia Valeria; Tseng, Ling-Ming; Liu, Mei-Ching; Lluch, Ana; Semiglazov, Vladimir; de la Haba-Rodriguez, Juan; Oh, Do-Youn; Poirier, Brigitte; Pedrini, Jose Luiz; Valagussa, Pinuccia; Gianni, Luca 分享 收藏
Long-term outcomes after adjuvant treatment of sequential versus combination docetaxel with doxorubicin and cyclophosphamide in node-positive breast cancer: BCIRG-005 randomized trial Mackey, J. R.; Pienkowski, T.; Crown, J.; Sadeghi, S.; Martin, M.; Chan, A.; Saleh, M.; Sehdev, S.; Provencher, L.; Semiglazov, V.; Press, M. F.; Sauter, G.; Lindsay, M.; Houe, V.; Buyse, M.; Drevot, P.; Hitier, S.; Bensfia, S.; Eiermann, W. 分享 收藏
.png){kind=icon}
.png){kind=icon}
.png)
CANCER RESEARCH.png)
.png){kind=icon}
分享.png){kind=icon}
收藏
OAAI